The U.S. Department of Justice issued an Order on April 22, 2026 immediately placing all FDA-approved marijuana products and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act (CSA).
A second order also signed by Acting Attorney General Todd Blanche sets a June 29, 2026 hearing to